Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs16827863 | chr2:232077670 | C/T | 0.000127 | 494 | 30.7 | 29.4 | 31.93 | KM Plot |
PRAD | rs1684885 | chr3:169958552 | A/G | 0.000189 | 494 | 26.4 | 31.23 | 31.07 | KM Plot |
PRAD | rs16850362 | chr1:202699532 | G/T | 1.02E-5 | 491 | 30.8 | 30.95 | 27.92 | KM Plot |
PRAD | rs16850379 | chr2:235001537 | C/T | 0.000177 | 489 | 32.27 | 28.57 | 28.77 | KM Plot |
PRAD | rs16850380 | chr2:235002241 | C/T | 0.00013 | 494 | 32.27 | 28.3 | 29.23 | KM Plot |
PRAD | rs16870018 | chr8:104078514 | T/C | 1.18E-8 | 488 | 31.07 | 28.07 | 25.67 | KM Plot |
PRAD | rs16906145 | chr9:22455714 | T/G | 7.38E-5 | 481 | 31.33 | 28.48 | 17.47 | KM Plot |
PRAD | rs16918955 | chr8:54163895 | C/T | 2.73E-6 | 492 | 31.32 | 26.93 | 49.93 | KM Plot |
PRAD | rs16919966 | chr11:6945451 | C/T | 4.89E-8 | 494 | 31.23 | 28.48 | 28.57 | KM Plot |
PRAD | rs16959637 | chr16:58047773 | G/A | 2.2E-5 | 485 | 30.8 | 31.37 | 44.3 | KM Plot |
PRAD | rs16959641 | chr16:58054099 | C/G | 2.34E-5 | 482 | 30.8 | 31.22 | 44.3 | KM Plot |
PRAD | rs16975402 | chr18:39468269 | C/T | 6.05E-8 | 494 | 29.63 | 35.95 | 29 | KM Plot |
PRAD | rs16975407 | chr18:39479441 | C/G | 0.000133 | 480 | 29.1 | 36.6 | 24.63 | KM Plot |
PRAD | rs17014331 | chr3:24241978 | A/G | 2.49E-6 | 494 | 24.58 | 28.8 | 31.27 | KM Plot |
PRAD | rs17033329 | chr2:107439757 | G/A | 1.38E-5 | 491 | 30.93 | 30.7 | 32.63 | KM Plot |